Found 45 matching trials
Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection PHASE3 This study was to assess whether sofosbuvir in combination with ribavirin (...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis PHASE4 This study will examine the safety, tolerability, and antiviral efficacy of...
Show More Location
Multiple Locations
Learn More & Join Trial
Neutrino Regimen for Treatment-experienced HCV GT1 Patients PHASE4 This study will evaluate the efficacy and safety of NEUTRINO regimen in Chi...
Show More Location
Liver Fibrosis Diagnosis and Treatment Centre, 302 Hospital
Learn More & Join Trial
SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection PHASE3 This study will assess the efficacy, safety, and tolerability of 16 or 24 w...
Show More Location
Multiple Locations
Learn More & Join Trial
Sofosbuvir Plus Ribavirin in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection PHASE2 This study is to evaluate the safety, tolerability, and antiviral activity ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection PHASE2 The primary objectives of this study are to evaluate the antiviral efficacy...
Show More Learn More & Join Trial
Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection PHASE2 This study was designed to assess the safety and efficacy of multiple inter...
Show More Location
Alabama Liver & Digestive Specialists
Learn More & Join Trial
Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Participants With Chronic Genotype 2 HCV Infection PHASE3 The primary objectives of this study are to evaluate the antiviral efficacy...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV Infection PHASE3 This study will evaluate the antiviral efficacy of sofosbuvir (SOF)/ledipas...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders PHASE2 The primary objectives of this study are to evaluate the antiviral efficacy...
Show More Location
Multiple Locations
Learn More & Join Trial